NVS logo

Novartis AG (NVS) Operating Profit

Annual Operating Profit

$14.54 B
+$4.78 B+48.88%

December 31, 2024

Summary

Performance

1-Year Change

+48.88%

3-Year Change

+44.63%

5-Year Change

+60.07%

15-Year Change

+67.13%

NVS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.52%
NVS annual operating income is higher than 99.52% of companies in Healthcare sector

High & Low

All-time High

$14.54 B
NVS annual operating income is currently at an all-time high

3-Year Low

$7.95 B
NVS annual operating income is currently +83.04% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSprofitabilitymetrics:

Annual Operating Margin

28.12%
NVS annual operating profit margin is 28.12%

Annual Revenue

$51.72 B
NVS annual revenue is $51.72 billion

Annual Net Income

$11.94 B
NVS annual net profit is $11.94 billion

Annual EPS

$5.87
NVS annual earnings per share is $5.87

Quarterly Operating Profit

$3.53 B
-$97.00 M-2.67%

December 31, 2024

Summary

Performance

3-Month Change

-2.67%

1-Year Change

+36.72%

3-Year Change

+100.34%

5-Year Change

+100.34%

NVS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.58%
NVS quarterly operating income is higher than 99.58% of companies in Healthcare sector

High & Low

All-time High

$5.70 B
NVS quarterly operating income is currently -38.04% below its historical high of $5.70 billion

3-Year Low

$929.00 M
NVS quarterly operating income is currently +279.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 23, 2025
NVS next earnings announcement is scheduled for Apr 23, 2025

OtherNVSprofitabilitymetrics:

Quarterly Operating Margin

26.04%
NVS quarterly operating profit margin is 26.04%

Quarterly Revenue

$13.56 B
NVS quarterly revenue is $13.56 billion

Quarterly Net Income

$2.82 B
NVS quarterly net profit is $2.82 billion

Quarterly EPS

$1.41
NVS quarterly earnings per share is $1.41

TTM Operating Profit

$14.54 B
+$948.00 M+6.97%

December 31, 2024

Summary

Performance

3-Month Change

+6.97%

1-Year Change

+48.88%

3-Year Change

+62.65%

5-Year Change

+62.65%

NVS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.49%
NVS TTM operating income is higher than 99.49% of companies in Healthcare sector

High & Low

All-time High

$14.54 B
NVS TTM operating income is currently at an all-time high

3-Year Low

$7.83 B
NVS TTM operating income is currently +85.63% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 23, 2025
NVS next earnings announcement is scheduled for Apr 23, 2025

OtherNVSprofitabilitymetrics:

Annual Operating Margin

28.12%
NVS annual operating profit margin is 28.12%

TTM Revenue

$51.72 B
NVS TTM revenue is $51.72 billion

TTM Net Income

$11.94 B
NVS TTM net profit is $11.94 billion

TTM EPS

$5.88
NVS TTM earnings per share is $5.88

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

$14.54 B
NVS annual operating income is $14.54 billion

Annual Gross Profit

$38.90 B
NVS annual gross profit is $38.90 billion

Annual Operating Expenses

$24.35 B
NVS annual total operating expenses is $24.35 billion

NVS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.9%+36.7%+48.9%
3 y3 years+44.6%+100.3%+62.6%
5 y5 years+60.1%+100.3%+62.6%

NVS Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+83.0%-12.1%+280.0%at high+85.6%
5 y5-yearat high+83.0%-12.1%+280.0%at high+85.6%
alltimeall timeat high+236.3%-38.0%+132.1%at high+724.2%

Novartis AG Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
$14.54 B(+48.9%)
$3.53 B(-2.7%)
$14.54 B(+7.0%)
Sep 2024
-
$3.63 B(-9.6%)
$13.60 B(+15.9%)
Jun 2024
-
$4.01 B(+19.0%)
$11.73 B(+11.5%)
Mar 2024
-
$3.37 B(+30.6%)
$10.52 B(+7.7%)
Dec 2023
$9.77 B(+22.9%)
$2.58 B(+46.5%)
$9.77 B(+9.2%)
Sep 2023
-
$1.76 B(-37.2%)
$8.94 B(-0.7%)
Jun 2023
-
$2.81 B(+7.2%)
$9.01 B(+6.9%)
Mar 2023
-
$2.62 B(+49.2%)
$8.43 B(-2.7%)
Dec 2022
$7.95 B(-21.0%)
$1.75 B(-3.9%)
$8.66 B(+10.5%)
Sep 2022
-
$1.83 B(-18.0%)
$7.83 B(-15.2%)
Jun 2022
-
$2.23 B(-21.9%)
$9.24 B(-11.9%)
Mar 2022
-
$2.85 B(+207.0%)
$10.49 B(+4.3%)
Dec 2021
$10.06 B(-0.9%)
$929.00 M(-71.3%)
$10.06 B(-14.6%)
Sep 2021
-
$3.23 B(-7.1%)
$11.77 B(+7.5%)
Jun 2021
-
$3.48 B(+44.1%)
$10.95 B(+11.5%)
Mar 2021
-
$2.42 B(-8.7%)
$9.82 B(-3.2%)
Dec 2020
$10.15 B(+11.7%)
$2.64 B(+9.6%)
$10.15 B(+8.8%)
Sep 2020
-
$2.41 B(+2.6%)
$9.33 B(+0.6%)
Jun 2020
-
$2.35 B(-14.3%)
$9.28 B(-3.2%)
Mar 2020
-
$2.74 B(+50.5%)
$9.59 B(+5.5%)
Dec 2019
$9.09 B(+8.1%)
$1.82 B(-22.7%)
$9.09 B(+5.3%)
Sep 2019
-
$2.36 B(-11.5%)
$8.63 B(+1.4%)
Jun 2019
-
$2.66 B(+18.8%)
$8.51 B(+2.8%)
Mar 2019
-
$2.24 B(+64.6%)
$8.27 B(-1.5%)
Dec 2018
$8.40 B(-3.4%)
$1.36 B(-39.2%)
$8.40 B(-8.5%)
Sep 2018
-
$2.24 B(-7.9%)
$9.18 B(-1.3%)
Jun 2018
-
$2.43 B(+2.5%)
$9.30 B(+1.7%)
Mar 2018
-
$2.37 B(+10.6%)
$9.15 B(+5.2%)
Dec 2017
$8.70 B(+5.2%)
$2.14 B(-9.1%)
$8.70 B(+8.6%)
Sep 2017
-
$2.36 B(+3.4%)
$8.01 B(+1.1%)
Jun 2017
-
$2.28 B(+18.6%)
$7.93 B(+2.4%)
Mar 2017
-
$1.92 B(+32.1%)
$7.74 B(-6.4%)
Dec 2016
$8.27 B(-7.9%)
$1.46 B(-35.9%)
$8.27 B(-2.6%)
Sep 2016
-
$2.27 B(+8.4%)
$8.49 B(+0.4%)
Jun 2016
-
$2.09 B(-14.6%)
$8.46 B(-2.2%)
Mar 2016
-
$2.45 B(+46.2%)
$8.64 B(-3.7%)
Dec 2015
$8.98 B(-19.0%)
$1.68 B(-24.9%)
$8.98 B(-7.0%)
Sep 2015
-
$2.23 B(-2.1%)
$9.65 B(-5.0%)
Jun 2015
-
$2.28 B(-18.1%)
$10.16 B(-8.2%)
Mar 2015
-
$2.79 B(+18.5%)
$11.06 B(-0.3%)
Dec 2014
$11.09 B(+1.0%)
$2.35 B(-14.2%)
$11.09 B(+0.2%)
Sep 2014
-
$2.74 B(-14.0%)
$11.07 B(+1.7%)
Jun 2014
-
$3.18 B(+13.1%)
$10.89 B(+1.4%)
Mar 2014
-
$2.81 B(+20.7%)
$10.74 B(-0.7%)
Dec 2013
$10.98 B(-4.6%)
$2.33 B(-8.8%)
$10.82 B(-3.4%)
Sep 2013
-
$2.56 B(-15.7%)
$11.20 B(-3.4%)
Jun 2013
-
$3.03 B(+4.7%)
$11.59 B(-0.6%)
Mar 2013
-
$2.90 B(+6.7%)
$11.67 B(+1.4%)
Dec 2012
$11.51 B
$2.71 B(-7.9%)
$11.51 B(+16.3%)
Sep 2012
-
$2.95 B(-5.1%)
$9.89 B(-0.0%)
Jun 2012
-
$3.11 B(+13.6%)
$9.89 B(-2.1%)
DateAnnualQuarterlyTTM
Mar 2012
-
$2.74 B(+149.0%)
$10.11 B(-6.2%)
Dec 2011
$10.78 B(-6.5%)
$1.10 B(-62.8%)
$10.78 B(-11.3%)
Sep 2011
-
$2.95 B(-11.2%)
$12.15 B(+3.1%)
Jun 2011
-
$3.32 B(-2.5%)
$11.78 B(+3.2%)
Mar 2011
-
$3.41 B(+38.1%)
$11.42 B(-0.9%)
Dec 2010
$11.53 B(+15.5%)
$2.47 B(-4.6%)
$11.53 B(-1.5%)
Sep 2010
-
$2.59 B(-12.6%)
$11.70 B(-0.4%)
Jun 2010
-
$2.96 B(-15.7%)
$11.74 B(+5.4%)
Mar 2010
-
$3.51 B(+33.1%)
$11.15 B(+14.2%)
Dec 2009
$9.98 B(+11.4%)
$2.64 B(+0.1%)
$9.76 B(+10.9%)
Sep 2009
-
$2.63 B(+11.4%)
$8.80 B(+3.5%)
Jun 2009
-
$2.36 B(+11.3%)
$8.50 B(-1.1%)
Mar 2009
-
$2.12 B(+26.4%)
$8.60 B(-4.1%)
Dec 2008
$8.96 B(+32.2%)
$1.68 B(-28.1%)
$8.96 B(+18.1%)
Sep 2008
-
$2.33 B(-5.1%)
$7.59 B(+4.0%)
Jun 2008
-
$2.46 B(-1.1%)
$7.30 B(+6.0%)
Mar 2008
-
$2.49 B(+710.4%)
$6.88 B(+2.3%)
Dec 2007
$6.78 B(-11.3%)
$307.00 M(-85.0%)
$6.73 B(-17.4%)
Sep 2007
-
$2.04 B(-0.1%)
$8.15 B(+0.8%)
Jun 2007
-
$2.04 B(-12.4%)
$8.08 B(-0.2%)
Mar 2007
-
$2.33 B(+35.4%)
$8.10 B(+3.5%)
Dec 2006
$7.64 B(+17.4%)
$1.73 B(-12.8%)
$7.83 B(+8.8%)
Sep 2006
-
$1.98 B(-4.2%)
$7.19 B(+1.3%)
Jun 2006
-
$2.06 B(+0.3%)
$7.10 B(+3.1%)
Mar 2006
-
$2.06 B(+88.8%)
$6.88 B(+5.8%)
Dec 2005
$6.51 B(+6.4%)
$1.09 B(-42.3%)
$6.51 B(-0.3%)
Sep 2005
-
$1.89 B(+2.1%)
$6.53 B(+2.7%)
Jun 2005
-
$1.85 B(+10.1%)
$6.36 B(+0.9%)
Mar 2005
-
$1.68 B(+51.1%)
$6.30 B(+3.0%)
Dec 2004
$6.12 B(+8.6%)
$1.11 B(-35.2%)
$6.12 B(-3.8%)
Sep 2004
-
$1.72 B(-4.3%)
$6.36 B(+4.1%)
Jun 2004
-
$1.79 B(+20.1%)
$6.11 B(+5.7%)
Mar 2004
-
$1.49 B(+10.5%)
$5.78 B(+2.5%)
Dec 2003
$5.63 B(+10.7%)
$1.35 B(-8.0%)
$5.63 B(+0.1%)
Sep 2003
-
$1.47 B(+0.4%)
$5.63 B(+4.2%)
Jun 2003
-
$1.46 B(+8.3%)
$5.40 B(+0.4%)
Mar 2003
-
$1.35 B(+0.4%)
$5.38 B(-39.5%)
Dec 2002
$5.09 B(+17.7%)
$1.35 B(+8.4%)
$8.89 B(-481.5%)
Sep 2002
-
$1.24 B(-13.9%)
-$2.33 B(-216.3%)
Jun 2002
-
$1.44 B(-70.3%)
$2.00 B(+30.7%)
Mar 2002
-
$4.86 B(-149.2%)
$1.53 B(+37.5%)
Dec 2001
$4.33 B(-11.4%)
-$9.87 B(-277.0%)
$1.11 B(>+9900.0%)
Sep 2001
-
$5.58 B(+474.3%)
$0.00(-100.0%)
Jun 2001
-
$971.00 M(-78.1%)
-$695.00 M(+4.4%)
Mar 2001
-
$4.44 B(-140.4%)
-$666.00 M(-212.7%)
Dec 2000
$4.88 B(+5.9%)
-$10.99 B(-325.1%)
$591.00 M(-94.9%)
Sep 2000
-
$4.88 B(+388.1%)
$11.58 B(+72.9%)
Jun 2000
-
$1.00 B(-82.4%)
$6.70 B(+17.6%)
Mar 2000
-
$5.70 B
$5.70 B
Dec 1999
$4.61 B(-8.3%)
-
-
Dec 1998
$5.03 B
-
-

FAQ

  • What is Novartis AG annual operating income?
  • What is the all time high annual operating profit for Novartis AG?
  • What is Novartis AG annual operating profit year-on-year change?
  • What is Novartis AG quarterly operating income?
  • What is the all time high quarterly operating profit for Novartis AG?
  • What is Novartis AG quarterly operating profit year-on-year change?
  • What is Novartis AG TTM operating income?
  • What is the all time high TTM operating profit for Novartis AG?
  • What is Novartis AG TTM operating profit year-on-year change?

What is Novartis AG annual operating income?

The current annual operating profit of NVS is $14.54 B

What is the all time high annual operating profit for Novartis AG?

Novartis AG all-time high annual operating income is $14.54 B

What is Novartis AG annual operating profit year-on-year change?

Over the past year, NVS annual operating income has changed by +$4.78 B (+48.88%)

What is Novartis AG quarterly operating income?

The current quarterly operating profit of NVS is $3.53 B

What is the all time high quarterly operating profit for Novartis AG?

Novartis AG all-time high quarterly operating income is $5.70 B

What is Novartis AG quarterly operating profit year-on-year change?

Over the past year, NVS quarterly operating income has changed by +$948.00 M (+36.72%)

What is Novartis AG TTM operating income?

The current TTM operating profit of NVS is $14.54 B

What is the all time high TTM operating profit for Novartis AG?

Novartis AG all-time high TTM operating income is $14.54 B

What is Novartis AG TTM operating profit year-on-year change?

Over the past year, NVS TTM operating income has changed by +$4.78 B (+48.88%)